Effect of daunorubicin on dihydropyridine-sensitive binding sites in cardiac sarcolemma.
D000818:Animals; D002118:Calcium / Q000502:physiology*; D006224:Cricetinae; D003630:Daunorubicin / Q000494:pharmacology*; D004095:Dihydropyridines / Q000378:metabolism*; D005260:Female; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D017275:Isradipine; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D009543:Nifedipine / Q000378:metabolism; D010069:Oxadiazoles / Q000378:metabolism; D012508:Sarcolemma / Q000378:metabolism*
D004095:Dihydropyridines; D007473:Ion Channels; D010069:Oxadiazoles; D009543:Nifedipine; D002118:Calcium; D017275:Isradipine; D003630:Daunorubicin